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Introduction
Catheter ablation of atrial fibrillation (AF) utilizing radiofrequency (RF) or Cryothermal (Cryo) energy for pulmonary vein (PV) isolation (PVI) is a commonly performed procedure. Two ablation systems have received US Food and Drug Administration (FDA) approval for AF ablation: the irrigated RF system (Biosense Webster, Diamond Bar, CA, USA) and the Cryoballoon system (Medtronic Inc., Minneapolis, MN, USA). A third ablation modality, utilizing a balloon and infrared Laser (Cardiofocus, Marlborough, MA, USA), is currently undergoing clinical trials as part of an FDA evaluation process. 1 Magnetic resonance imaging (MRI) has been used to estimate the burden of left atrial (LA) fibrosis pre-and post-AF ablation in an effort to improve patient selection, and delineate the amount of scar formation postablation. [2] [3] [4] [5] Late gadolinium enhancement (LGE) MRI can detect ©2015 Wiley Periodicals, Inc.
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November 2015 ablated regions, 6 with evolution of the pattern and intensity of signal over time likely signifying initial edema followed by scar formation. 7 Previous studies have demonstrated that AF recurrence during the first year post-RF ablation is associated with a lesser degree of LA scarring on three-dimensional (3D) LGE MRI. 8 In addition, scar identified by LGE after initial catheter ablation of AF has been correlated to low-voltage regions on repeat electroanatomic mapping. 9, 10 We sought to compare, for the first time, the preand postprocedural LA scar size and patterns between RF-, Cryo-, and Laser-based pulmonary vein isolation techniques.
Methods

Study Population
In this prospective study we enrolled 17 patients with symptomatic drug-refractory AF referred for PVI at our institution between September 2011 and December 2013. The institutional Review Board approved the protocol and all patients provided written informed consent. Patient information gathered for the purposes of the study was de-identified and protected in compliance with Health Insurance Portability and Accountability Act of 1996 (HIPAA) regulations.
Pulmonary Vein Isolation
At the time of ablation, patients underwent single (Cryo) or double (RF, Laser) trans-septal puncture using standard techniques. In all patients, the pulmonary veins were isolated in standard fashion using a wide circumferential approach during RF, or per previously established protocols for Cryo or Laser. 11, 12 No one in the Cryo or Laser groups required segmental ablation using an irrigated RF catheter after primary isolation. Upon isolation of the pulmonary veins, catheters and sheaths were removed and the patients underwent follow-up in the usual manner. Symptom prompted and scheduled (6 months) monitoring for AF recurrence was performed using AfibAlert monitors (Lohman Technologies, Sussex, WI, USA).
MRI
All patients underwent MRI examinations using a 1.5 Tesla (T) Avanto scanner (Siemens, Erlangen, Germany) with a phased array cardiac coil prior to ablation, and at 24 hours, and 3 months post-AF ablation. The LGE-MRI images were acquired after a delay time of 20 minutes following the injection of 0.2 mmol/kg of gadolinium contrast (gadopentetate dimeglumine; Bayer Healthcare Pharmaceuticals, Montville, NJ, USA), at an injection rate of 2 mL/s followed by 20-mL saline flush. The LGE-MRI sequence utilized a 3D inversion recovery-prepared fast spoiled gradient recalled sequence that is respiratory triggered and navigated, electrocardiogram gated, and fat suppressed. The respiratory navigator is positioned on the right hemidiaphragm to limit gating artifacts. The LGE-MRI images are acquired with phase encoding views during LA diastole. The inversion time (TI) was identified with a scout scan (240-300 ms) to maximize the conspicuity of abnormal LA myocardium. Other LGE-MRI parameters included repetition time (TR) 3.8 ms, echo time (TE) 1.52 ms, field of view (FOV) 340 mm, and flip angle (FA) 10°. A parallel imaging technique, Generalized Autocalibrating Partially Parallel Acquisition (GRAPPA), was used to accelerate image acquisition. Only two MRI exams were performed during AF (one patient prior to RF and the other prior to Laser ablation) and the remaining were performed during sinus rhythm. Consistent with our prior methodology, the image acquisition protocol was identical in all patients regardless of rhythm.
5,10
Image analysis
Images were processed off-line using QMass MR software (Version 7.2, Leiden University Medical Center, Leiden, the Netherlands) and OsiriX imaging software version 5.0.2 (OsiriX Foundation, Geneva, Switzerland). Multiplanar reconstructions (MPR) using axial planes of 3.5-mm thickness were prepared from LGE-MRI 3D images. For quantitative scar analysis, manual contours were drawn around the LA epicardium and endothelium on individual MPR axial planes. The LA myocardium in each image plane between the epicardial and the endocardial contours was then divided into 20 circumferential segments and the average image intensities of each segment were obtained. The image intensity ratio (IIR), defined as local atrial myocardial signal intensity divided by the mean blood pool image intensity, was calculated as previously reported. 4 The IIR was employed to objectively quantify LGE extent and intensity in the entire atrium and in the focused PV antral regions where comparisons were made. The PV antrum was defined as myocardium within 1 cm of the PV-LA junction. Postablation LGE-MRI images at 24 hours and 3-month postablation were analyzed in a similar manner. The IIR measures for the entire LA and for pulmonary vein antra were tabulated as panel data, at each time point, for individual patients. For qualitative 3D scar visualization, contours from QMass were transferred to OsiriX software. Volume rendering with ray-cast engine with linear table opacity was applied for better visualization of contrast-enhanced tissue. A color look-up table mask was applied for better differentiation and 
Visualization of fibrosis using LGE-MRI after ablation by (A) radiofrequency (RF), (B) Cryothermal, and (C) Laser energy application at baseline (first column), postablation at 24 hours (second column) and 3 months (third column). The figures illustrate normal myocardium in green and enhanced (scar myocardium) in red. Yellow regions signify mild enhancement. The extent of atrial enhancement was increased at 24 hours postablation by all energy sources. The extent of enhancement, however, was highest in the RF and Cryo groups at 24 hours postablation. At 3 months, Laser energy was associated with focused linear lesions compared to the diffuse lesion
Statistical Analysis
Continuous variables are presented as mean ± standard deviation and categorical data are presented as percentages. Baseline characteristics were compared using analysis of variance, chisquared, or Fisher's exact tests as indicated. To account for intrapatient clustering of data and interpatient differences in baseline scar, linear mixed-effects regression models, clustered by patient, were used to examine the association of time (with linear spline at 24 hours) and ablation modality with scar extent or PV antral IIR post-AF ablation. Statistical analyses were performed using STATA software (version 12; StataCorp, College Station, TX, USA).
Results
Patient Population
Seventeen patients underwent PVI for the treatment of AF in this study. Of these patients, seven (41.2%) underwent RF ablation, five (29.4%) underwent Cryo ablation, and five (29.4%) underwent Laser ablation. Table  I describes the baseline characteristics of all patients and of patient groups by energy source. The mean age was 57 ± 9 years and 77% of patients were male. No statistically significant differences in baseline characteristics were noted across groups. At a mean follow-up of 6.3 ± 2.3 months, 13 (76.5%) patients remained in sinus rhythm; five (71.4%) patients in the RF group, four (80.0%) in the Cryo group, and four (80.0%) in the laser group.
LA Scar Burden before and after Pulmonary Vein Isolation
Shown in Figure 1 are representative 3D images of LA fibrosis at baseline, 24 hours, and 3 months post-RF, Cryo, or Laser ablation. The figure illustrates normal myocardium in green and enhanced (scar myocardium) in red, with yellow regions signifying mild enhancement. The extent of atrial enhancement was increased at 24 hours postablation in a diffuse pattern (+14.7 ± 8.1% of LA myocardium, P < 0.001). At 3 months, the PACE, Vol. 38
November 2015 extent of enhancement was unchanged (+5.0 ± 14.3%, P = 0.818). Laser energy caused focused linear lesions compared to the diffuse lesion sets associated with RF and Cryo ablation as seen on three-month images attained in the Laser group. An example is presented in Videos 1 and 2, which illustrate baseline and 3-month LGE patterns, respectively, in a patient who underwent laser ablation. Additionally, regression of LGE intensity toward baseline was noted at the LA with the exception of the PV antra, where progression of enhancement was noted at 3 months postablation with all modalities. Table II contains individual patient data regarding mean LGE IIR measures at each time point and the scar burden per individual and in aggregate per patient group. In the RF group, the mean scar burden was 29.0 ± 6.8% of LA myocardium before ablation, 46.9 ± 5.7% of LA myocardium at 24 hours, and 46.3 ± 3.6% of LA myocardium at 3 months postablation. In the Cryo group, the mean scar burden was 38.0 ± 10.7% of LA myocardium at baseline, 47.8 ± 5.4% of LA myocardium 24 hours after ablation, and 50.0 ± 8.6% of LA myocardium at 3 months postablation. In the Laser group the mean scar burden was 28.0 ± 11.4% of LA myocardium before ablation, 43.7 ± 3.8% of LA myocardium at 24 hours, and 41.8 ± 4.6% of LA myocardium at 3 months postablation.
The individual trajectory of scar burden as a function of time and ablation energy source has been summarized graphically in Figure 2 . In a linear mixed effects regression model, with a time spline at 24 hours, and accounting for intrapatient clustering of data and interpatient differences in baseline scar, LGE extent was significantly increased at 24 hours (+14.6 ± 1.9% of LA myocardium, P < 0.001) postablation and remained stable from 24 hours to 3 months (+0.1 ± 1.9%, P = 0.951). In this model, there was no statistically significant difference between the postablation changes in scar burden among ablation modalities when compared to RF (Cryo +4.5 ± 3.0%, P = 0.123; Laser -3.2 ± 3.0%, P = 0.291).
Pulmonary Vein Antral LGE Intensity
Secondary analyses were performed by limiting the comparison of image intensities to the pulmonary vein antra to determine intensity changes purely attributable to the energy modality utilized for ablation. In the group that underwent RF ablation, the mean pulmonary vein antral PACE, Vol. 38
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IIR values were 0.93 ± 0.11 at baseline, 1.24 ± 0.10 at 24 hours, and 1.29 ± 0.10 at 3 months postablation. In the group that underwent cryo ablation, the mean pulmonary vein antral IIR was 1.03 ± 0.10 at baseline, 1.17 ± 0.08 at 24 hours, and 1.17 ± 0.08 at 3 months postablation.
In the group that underwent Laser ablation, the mean pulmonary vein antral IIR was 0.92 ± 0.09 at baseline, 1.16 ± 0.21 at 24 hours postablation, and 1.40 ± 0.22 at 3 months postablation as seen in Figure 3(B) . In a linear mixed effects regression model, with a time spline at 24 hours, and accounting for intrapatient clustering of data and interpatient differences in baseline intensity, the IIR at the pulmonary vein antra was significantly increased at 24 hours (+0.25 ± 0.04, P < 0.001) postablation and further increased from 24 hours to 3 months (+0.08 ± 0.04, P = 0.033). In this model, there was no statistically significant difference between the postablation changes in pulmonary vein antral intensity among the energy modalities (Cryo versus RF: -0.03 ± 0.06, P = 0.600, and Laser versus RF: +0.02 ± 0.06, P = 0.711).
Discussion
This report is the first to describe the burden of LA scar and image intensity of regions ablated by RF, Cryo, and Laser energy sources at baseline, 24 hours, and 3 months post-AF ablation. Lesion formation and durability has been demonstrated to have clinical implications regarding the recurrence of AF after ablation. 8, 13 Therefore, evaluation of scar burden acutely after ablation and at long-term follow-up may have important implications regarding the performance of each energy source. We found that the extent of atrial enhancement was significantly increased at 24 hours postablation and remained stable at 3 months and extent of enhancement is similar by the three modalities. Although laser energy appeared to cause qualitatively more focused lesions on postablation images (Fig. 1) , this finding did not reach statistical significance.
Radiofrequency, Cryothermal, and Laser Ablation Patterns
RF energy (frequencies between 300 and 1000 kHz) is the standard energy source used for catheter ablation. Passage of high frequency current with high density through a catheter tip and into the myocardium leads to conversion of electromagnetic energy to mechanical energy and heat production through resistive heating. Cryo catheters deliver a pressurized liquid refrigerant, such as nitrous oxide, to an expansion chamber at the tip where evaporation of the liquid refrigerant leads to absorption of heat from the surrounding catheter surface and myocardium. Freezing of extracellular fluid results in a hyperosmotic extracellular environment that desiccates the cells, damaging the cell membrane and constituents. Further cooling results in freezing of the cellular fluid and disruption of the intracellular organelles and membranes, resulting in complete cell death.
14 Laser ablation utilizes a high-intensity flash of infrared light to heat exposed tissue. The Cardiofocus Laser ablation system utilizes a diode source, which produces a beam with a wavelength of 980 nm. 15 Absorption of diode Laser energy by the myocardium results in heating with minimal scatter and therefore minimal lesion enlargement.
A prior abstract by Mankhopf and colleagues compared the pre and postprocedure lesion formation characteristics of Cryoballoon to RF ablation using LGE-MRI. 16 The authors achieved PVI in 21 (87.5%) of 24 patients who underwent Cryo ablation and all 48 patients in the RF group (P = 0.03). Patients with recurrences were found to have a higher amount of fibrosis prior to ablation. In their multi-center experience the authors reported a similar pattern of LA structural remodeling with Cryo and RF ablation. 16 Our findings are in agreement with this previous report in that the extent of LGE and contrast wash-in wash-out kinetics are similar between RF and Cryo ablation. We also included a group that had undergone laser ablation and found similar contrast kinetics with to those of RF and Cryo. Additionally, we normalized the mean IIR values, from the entire atrium and PV antral areas from 24 hours and 3-month images to the baseline IIRs. Figure 4 describes the impact of each ablation modality on the extent of enhancement on LGE-MRI at the two followup periods using normalized IIR measures in the LA (Fig. 4A ) and in the PV antrum (Fig.  4B) . It is clear that the enhancement changes due to all modalities are similar in pattern. RF ablation caused increased enhancement in the entire LA and PV antrum that persisted over time. Cryo ablation also increased acute enhancement. Although at 3 months the enhancement with Cryo had regressed in the entire LA, it had intensified in the PV antral myocardium. Laser ablation caused diffusely increased enhancement in the LA at 24 hours, but the increased enhancement was focused in the PV antrum at 3 months.
Previous studies have suggested that the extent of scar after RF ablation positively associates with ablation success. 8, 13 Based upon previous findings with RF, one might expect that given the smaller extent of postablation scar with Laser, results would be inferior to RF and Cryo. Conversely, the extent of scar in prior studies with RF may have served as a surrogate of the completeness of linear ablation, and a complete Laser line may achieve the same efficacy with less tissue destruction. Additional studies are needed to examine freedom from AF as well as the extent of fibrosis and atrial function following ablation with each modality.
Limitations
The primary shortcoming of our study is the limited sample size of participants. Larger sample sizes will be necessary to compare atrial remodeling among groups of participants assigned to different energy sources. Consecutive patients referred for catheter ablation were approached regarding the study, but many patients refused participation due to the necessity for three separate MRI examinations. Additionally, this was an observational cohort and participants were not randomized to different energy sources. Although there were no significant differences in baseline characteristics, unobserved differences may have existed. The analyses are unadjusted for the number of lesions applied in each patient and at each PV antrum. Finally, to improve signal to noise ratio, multiplanar reconstructions were performed prior to image analyses resulting in 1.3×1.3×3.5-mm image resolution. However, atrial wall thickness may be near the limit of image resolution in some participants. Due to volume averaging, our intensity measures may be affected by blood pool or epicardial fat in some cases. However, the association of image intensity with voltage measures in our prior studies suggests that, on average, the measures represent LA myocardial tissue characteristics.
4,5,10
Conclusions
Our results demonstrate that radiofrequency, cryoablation, and Laser energy reliably change contrast kinetics in the LA in a pattern consistent with PV antral fibrotic change. Our preliminary data suggest that the extent of ablation with Cryo and Laser is more focused around the PV antra at 3 months. Additional studies to characterize the association of various ablative energy sources with atrial remodeling and clinical recurrences of AF are warranted.
